	Prospective study on mental status in rheumatoid arthritis patients on tumour necrosis factor vs non- tumour necrosis factor-targeted therapies after achieving treatment target. Rheumatology (Oxford) Fujii T, Murata K, Nakabo S, Onishi A, Murakami K, Tanaka M, Morinobu A, Matsuda S. PMID: 41206652 [PubMed - as supplied by publisher]
	Lifetime occupational and para-occupational exposure to organic solvents and testicular germ cell tumor risk: a French case-control study-TESTIS. Int J Epidemiol Guth M, Lefevre M, Coste A, Praud D, Perol O, Pilorget C, Dananché B, Danjou A, Perrin J, Drouineaud V, Bujan L, Schüz J, Olsson A, Charbotel B, Fervers B, TESTIS Study Group. PMID: 41206641 [PubMed - in process]
	Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial. Br J Surg PMID: 41206578 [PubMed - in process]
	Streamlining care through patient navigation: a retrospective cohort study of timely anti-HER2 therapy in early breast cancer in a low-middle income country. BMC Health Serv Res Shash E, Alaa F, Maher E, Rostom JF, Ibrahim A, Said R, El-Kheir NA, Elhosary M, Eid R. PMID: 41206463 [PubMed - in process]
	Toripalimab combined with FLOT chemotherapy as conversion therapy for gastric cancer with peritoneal metastasis: a single-arm, open-label, phase II trial. BMC Cancer Zhang Z, Lin Z, Xu Y, Luo L, Zeng H, Xiong W, Chen Y, Peng Y, Yang T, Zheng Y, Li J, Huang H, Wang W. PMID: 41206442 [PubMed - in process]
	Prognostic evaluation of glycolysis markers in hepatocellular carcinoma: insights from meta-analysis and multi-omics approaches. BMC Med Genomics Li G, Li Y, Zhou J, Tang S, Guo H, Lin J. PMID: 41206438 [PubMed - in process]
	Nomogram Based on Pan-Immune Inflammation Value and ClinicopathologicalÂ Parameters for Predicting the Recurrence of Endometrial Cancer and Providing Postoperative Prognostic Management. Ann Surg Oncol Long J, Tian C, Tu Y, Gong C, Yu J, Xiong J, Jiang P. PMID: 41206403 [PubMed - as supplied by publisher]
	Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology. Br J Cancer Phillips R, Basu B, Butt Z, Beloueche M, Cook N, Crabb SJ, Greystoke A, Hargrave D, Jones R, Kureeman MY, Lopez J, McKeeve C, Meissner M, O'Carrigan B, Parkes EE, Ronghe M, Roxburgh P, Sarker D, Savage KI, Shaw PHS, Symeonides S, Tweddle DA, Vedi A, Walter HS, Zabkiewicz J, Middleton GW, Beggs AD. PMID: 41206382 [PubMed - as supplied by publisher]
	The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History. Clin Lymphoma Myeloma Leuk Mutlu YG, Emre Ünsal , Güleç B, Serin , Arslan Davulcu E, Sönmez GM, Güven S, Yi, Maral S, Keklik M, Saliho, Cetintepe T, Cengiz Seval G, Sevindik ÖG. PMID: 41206323 [PubMed - as supplied by publisher]
	Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol Ng CPY, Light A, Eragamreddy SK, Boaz RJ, Hunter A, Ashour O, Alderton D, Nicholls L, Hug O, Ang JZ, Raja A, Chua C, Hasan H, Wong F, Matthews M, Bhola-Stewart H, Adzawoloo-Andersson I, Mendoza R, Smith A, Lloyd J, Yeung M, Silvanto A, Mannion E, Lakhani A, Rockall A, Clark M, Tam H, Tanaka MB, Winkler M, Ahmed HU, Shah TT. PMID: 41206290 [PubMed - as supplied by publisher]
	Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial. Eur Urol Oncol Zilli T, Böhmer D, Roeder A, Lauffer D, Villafranca Iturre AE, Jové-Teixidó JJ, Supiot S, Latorzeff I, Dirix P, Otte FX, Francolini G, Roumeguère T, Simon JM, Fournier B, Fortpied C, Lara PC, Tombal B. PMID: 41206286 [PubMed - as supplied by publisher]
	Breast cancer imaging without gadolinium-based contrast agent: A review of current applications and future trends. Diagn Interv Imaging Honda M, Iima M, Kataoka M, Ueda D, Saida T, Nishioka K, Kurokawa R, Ide S, Yanagawa M, Watabe T, Hirata K, Ito R, Oda S, Takumi K, Kawamura M, Sugawara S, Sofue K, Sakata A, Naganawa S. PMID: 41206276 [PubMed - as supplied by publisher]
	Performance of Machine Learning Models Based on Medical Imaging in Predicting the expression of PD-L1 and CD8+TILs in Thoracic cancer: A Systematic Review and Meta-Analysis. Acad Radiol Liu M, Gong J, Liu Y, Meng F, Shi Z, Cui Y, Zhao L. PMID: 41206268 [PubMed - as supplied by publisher]
	Mechanisms of whole-genome doubling in cancer evolution. Trends Cancer McKenney CD, Regot S. PMID: 41206259 [PubMed - as supplied by publisher]
	Factors that affect engagement with physical activity for patients who have received radiotherapy as part of their gynaecological cancer treatment - A rapid review. Radiography (Lond) Gilligan T, Robinson A. PMID: 41206249 [PubMed - as supplied by publisher]
	PSA response to predict progression in metastatic hormone-sensitive prostate cancer (mHSPC) patients. When is the optimal time point? Urol Oncol Martínez-Corral R, Pérez-Fentes D, Bardella-Altarriba C, Vera-Ballesteros FJ, Abella-Serra A, Antón Fuente S, Martínez-Corral ME, Picola-Brau N, López-Abad A, Gómez-Ferrer Á, Beamud-Cortés M, Suárez-Novo JF, López-González PA, García-Puche M, Álvarez-Gracia AM, De Pablos-Rodríguez P. PMID: 41206248 [PubMed - as supplied by publisher]
	High Thymidine Kinase 1 Activity Linked to Poor Breast Cancer Survival: A Systematic Review and Meta-Analysis. Clin Breast Cancer Li S, Tang G, Lin S, Guan X, Qin W, Xiao X. PMID: 41206233 [PubMed - as supplied by publisher]
	Colorectal cancer stage at diagnosis in male Florida firefighters. JNCI Cancer Spectr Gould Rothberg BE, Koru-Sengul T, Zhao W, Hernandez MN, Negron S, Pinilla V, Solle NS, Kobetz EN, Pinheiro PS, Lee DJ. PMID: 41206125 [PubMed - as supplied by publisher]
	Physical health outcomes and step cadence improvements: a digital physical activity intervention in cancer survivors. JNCI Cancer Spectr Bates-Fraser LC, Masters M, Donzella SM, Chiang KE, Whalen S, Zhong C, Swain CTV, Tam R, Sullivan K, Hartman SJ, Patel AV, Rees-Punia E. PMID: 41206120 [PubMed - as supplied by publisher]
	TMBclaw: tumor clone-aware graph learning improves immunotherapy response prediction across heterogeneous cohorts. Brief Bioinform Wang Y, Zhu T, Song X, Chen P, Zhu X, Chang Z, Wang X, Lai X, Wang J. PMID: 41206114 [PubMed - in process]

Articles 1 - 20 / 1857543

Page 1 of 92878



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy